A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma
Clinical trial NCT07107178 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07107178
- Sponsor
- Biotroy Therapeutics
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-08
- Primary completion
- 2027-05-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.